Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the U.S.A.

Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the U.S.A.

March 29, 2018

First published: 29 March 2018
 

This summary relates to https://doi.org/10.1111/bjd.15939

British Journal of Dermatology, 178, 709–714, March 2018

Summary

Hidradenitis suppurativa (HS) is a chronic, recurrent, and painful disease in which there is inflammation in areas of the apocrine sweat glands. These glands are found mainly in the armpits and groins. Within HS there may be a blockage of the hair follicles. This causes a mixture of boil-like lumps, areas leaking pus, and scarring. Despite a common belief that tobacco smoking increases the risk of developing the disease, the evidence linking the two is controversial. This study is important because it includes a very large sample of people to compare rates of HS in smokers and non-smokers. Using healthcare data, the researchers identified 3 924 310 tobacco smokers and 8 027 790 non-smokers in the USA and found that the overall incidence of HS was 0.20% among smokers and 0.11% among non-smokers. Incidence of HS was greatest among smokers who were aged 30–39 years (0.35%), women (0.28%), African Americans (0.46%), and those with BMI ≥ 30. In conclusion, incidence of HS appears to be doubled among tobacco smokers. These findings may support evidence-based counselling to help people at risk of HS to quit smoking.


Photo by Donny Jiang on Unsplash

Stay connected with the latest news, research updates, and community stories from the HS-Foundation.

Sign up for our email newsletter